Editor's Page: The Future of the Journal of Cardiac Failure: A Reinvigorated Focus on People, Partnerships and Presentation. @dranulala @robmentz

🚨#ESC2025: Don't miss this 🌟 SotA review that delves into the latest frontiers of OHT, including 🫀 preservation/transport, decision-making 🤔 re OHT vs LVAD for "net survival benefit", precision immunosuppression & surveillance, & donor-pool expansion.🔗

Join millions who have switched to Grok.

#ESC2025 Check out this new meta-analysis that harmonizes data from all phase-3 trials assessing disease-specific Rx in ATTR-CM. There were early improvements in biomarkers, QoL & functional capacity, followed by⬇️CV events & ACM with continued treatment.🔗

RT @HFSA: Starting out in heart failure? You’re not alone. Join HFSA for a free mentoring webinar designed for trainees and early-career p….

“By weaving together cardiovascular prevention and heart failure care into one cohesive framework, clinicians can be EMPOWERED to take meaningful action at every stage—" . 🔗 #Prevention #JCF #MedicalPublishing #ContinuumOfCare #PreventativeCare.

New joint statement with @HFSA and @ASPCardio is out now!. @dranulala and @DrMarthaGulati explore how prevention and heart failure are interconnected across the cardiovascular care spectrum. 🫀 Read the statement: . #HeartFailure #Cardiology #HFSA #ASPC

RT @DrMarthaGulati: When #HeartFailure meets #CVPrev & it becomes the center of everything we do, we can start saving hearts. Our joint @AS….

RT @HFSA: 📢 Just released! A new scientific statement from @HFSA and @ASPCardio, jointly published in @JCardFail and @AJPCardio places prev….

Can what’s on your plate help treat heart failure? 🍽️ . @robmentz dives into what a decade of research says about medically tailored meals, and why they might be part of the future of HF care. 🫀. For more details on the study:

Sleep-disordered breathing is common in patients with heart failure, but are we identifying it early enough? 😴. Dr.@robmentz highlights key takeaways from new data on prevalence and predictors from the CHART-HF study. Read more from the study:

Is iron deficiency anemia associated w/ exercise capacity in patients with LVADs? 🏃 . Check out a quick take by @dranulala on a new JCF Brief Report exploring the link between iron deficiency anemia and pVO₂ on CPET. Dive deeper into the study here:

Call for Papers: Focus Issue: Infiltrative & Inflammatory Cardiomyopathies . Guest Editors Drs. Nisha Gilotra, Mat Maurer, and Emer Joyce will oversee this issue, publishing Winter 2026. Paper Categories & Topic Areas: . 📆 Deadline: Oct 6, 2025

Iron deficiency anemia is associated with ⬇️ pVO2 in HF. But what does it look like in patients with LVADs? 🤔. This brief report shows a linear association between TSAT and pVO2 in pts with LVADs ❤️‍🩹🩸. 🔗

🚨New analysis of ICM vs NICM in HF-CS using CCC-TN registry. ICM associated with:.⬆️comorbidities, pre-admission cardiac arrests.⬆️ RRT, ventilation.⬇️ transplant, similar LVAD rates.⬆️ Mortality. 💡Etiology matters—even with similar MCS & inotropes . 🔗

🔥 New JCF Ignite! 🚨 The Emerging Myth of PGD!. 📌 Should the term Primary Graft Dysfunction give way to "Primary Graft Recovery"?. 📌Bart et al propose a new definition of PGD for this new era of advanced organ preservation techniques. Learn more👇. 🔗

Do warmer 🔥☀️ temperatures ⬆️ risk of driveline infections?🚨 . 📌DLIs affect 40% of LVAD pts at 5 years .📌DLIs ⬆️mortality ⬆️ pump thrombosis & stroke, so prevention is 🔑 .📌Calì et al found ⬆️ temperature = ⬆️ risk of DLIs . Read more👇 .🔗

PROs provide valuable insight into pts health status, but can they be used to improve risk prediction in HF?. 💡In this study, adding PROs to risk models improved ability to predict adverse events. How does your HF program utilize PRO assessments? . 🔗

Still thinking about submitting? Time is running out.⏳. There are only a few days left to submit your work to the Journal of Cardiac Failure Hemodynamics Focus Issue. Make your research count. Deadline is June 30th. 🫀. #HeartFailure #MedicalJournal

ICYMI: The 2024 Impact Factor released last week - we’re thrilled to say that JCF received 8.2, up from 6.7 in 2023. ❤️‍🔥. To us, impact is creating a community that moves the field forward, educating patients and colleagues, & amplifying voices from all corners of cardiology. 🌎

You’ve still got time - but not much! There are 2 weeks left to be part of the Journal of Cardiac Failure Hemodynamics Focus Issue. 🫀. If you're working in this space, we want to hear from you. 🔗. #JCFImpact #AcademicPublishing

People. Experience. Community. Since 2020, it's been how we measure impact at JCF. When numbers reflect our mission, it's even sweeter 💜. 🎉 JCF’s 2024 Impact Factor is ⬆️ 8.2 (from 6.7 in 2023). 🫀 Watch how we’re making a difference ⬇️. @Hfsa @robmentz @dranulala